JP2025509352A5 - - Google Patents
Info
- Publication number
- JP2025509352A5 JP2025509352A5 JP2024553586A JP2024553586A JP2025509352A5 JP 2025509352 A5 JP2025509352 A5 JP 2025509352A5 JP 2024553586 A JP2024553586 A JP 2024553586A JP 2024553586 A JP2024553586 A JP 2024553586A JP 2025509352 A5 JP2025509352 A5 JP 2025509352A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- cov
- sars
- derivative
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263318640P | 2022-03-10 | 2022-03-10 | |
| US63/318,640 | 2022-03-10 | ||
| PCT/US2023/064063 WO2023173032A2 (en) | 2022-03-10 | 2023-03-09 | Recombinant newcastle disease viruses and immunogenic compositions for use in preventing covid-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025509352A JP2025509352A (ja) | 2025-04-11 |
| JP2025509352A5 true JP2025509352A5 (https=) | 2026-03-13 |
Family
ID=87936013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024553586A Pending JP2025509352A (ja) | 2022-03-10 | 2023-03-09 | Ｃｏｖｉｄ－１９の予防に使用するための組み換え型ニューカッスル病ウイルスおよび免疫原性組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250186578A1 (https=) |
| EP (1) | EP4489779A2 (https=) |
| JP (1) | JP2025509352A (https=) |
| KR (1) | KR20240161963A (https=) |
| CN (1) | CN119317446A (https=) |
| AU (1) | AU2023231285A1 (https=) |
| CA (1) | CA3245533A1 (https=) |
| CL (1) | CL2024002683A1 (https=) |
| CO (1) | CO2024012344A2 (https=) |
| MX (1) | MX2024011049A (https=) |
| WO (1) | WO2023173032A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021229270A1 (es) | 2020-05-13 | 2021-11-18 | Laboratorio Avi-Mex, S.A. De C.V. | Vacuna recombinante contra covid-19 en vector viral |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2251034T3 (pl) * | 2005-12-02 | 2018-07-31 | Icahn School Of Medicine At Mount Sinai | Chimeryczne wirusy prezentujące nienatywne białka powierzchniowe i zastosowania tych wirusów |
| MX2022013934A (es) * | 2020-05-07 | 2023-02-22 | Icahn School Med Mount Sinai | Virus de la enfermedad de newcastle recombinante que expresa la proteina de espicula de sars-cov-2 y usos del mismo. |
| US20250041402A1 (en) * | 2021-09-30 | 2025-02-06 | Icahn School Of Medicine At Mount Sinai | Recombinant newcastle disease virus expressing spike protein of sars-cov-2 delta variant and uses thereof |
-
2023
- 2023-03-09 CA CA3245533A patent/CA3245533A1/en active Pending
- 2023-03-09 CN CN202380026690.5A patent/CN119317446A/zh active Pending
- 2023-03-09 KR KR1020247033613A patent/KR20240161963A/ko active Pending
- 2023-03-09 EP EP23767708.3A patent/EP4489779A2/en active Pending
- 2023-03-09 AU AU2023231285A patent/AU2023231285A1/en active Pending
- 2023-03-09 JP JP2024553586A patent/JP2025509352A/ja active Pending
- 2023-03-09 WO PCT/US2023/064063 patent/WO2023173032A2/en not_active Ceased
- 2023-03-09 MX MX2024011049A patent/MX2024011049A/es unknown
- 2023-03-09 US US18/845,323 patent/US20250186578A1/en active Pending
-
2024
- 2024-09-06 CL CL2024002683A patent/CL2024002683A1/es unknown
- 2024-09-11 CO CONC2024/0012344A patent/CO2024012344A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12364749B2 (en) | RSV F protein mutants | |
| US9889194B2 (en) | Immunogenic composition for MERS coronavirus infection | |
| EP2970393B1 (en) | Heat-stable respiratory syncytial virus prefusion f protein oligomers and their use in immunological compositions | |
| GB2598494A (en) | A subunit vaccine for treatment or prevention of a respiratory tract infection | |
| JP6735269B2 (ja) | インフルエンザウイルスワクチンおよびその使用 | |
| JP2015509707A5 (https=) | ||
| RU2014135053A (ru) | Иммуногены для вакцинации против вич | |
| JP2021511077A (ja) | インフルエンザウイルスワクチン及びその使用 | |
| KR20230167017A (ko) | 인간 메타뉴모 바이러스 백신 | |
| WO2022135563A1 (zh) | 同时诱导抗多种病毒的免疫应答的方法 | |
| WO2023138334A1 (zh) | 一种重组新型冠状病毒蛋白疫苗、其制备方法和应用 | |
| JP2025509352A5 (https=) | ||
| CN102711818B (zh) | 抗rsv免疫原和免疫方法 | |
| WO2023138333A1 (zh) | 一种重组新型冠状病毒蛋白疫苗、其制备方法和应用 | |
| KR101366702B1 (ko) | 호흡기 신시치아 바이러스 백신 조성물 및 그의 제조방법 | |
| JP2023510544A5 (https=) | ||
| RU2788403C2 (ru) | Мутанты белка f rsv | |
| JP2024545462A (ja) | ワクチン組成物及びそれらの使用 | |
| HK40098178A (zh) | 人偏肺病毒疫苗 | |
| JP2020162607A (ja) | インフルエンザウイルスワクチンおよびその使用 |